Skip to main content

Ongoing research projects on COVID-19 funded by major Swedish funding agencies

This is a manually curated overview of research projects on COVID-19 which are funded by major funding agencies in Sweden. New projects are added on an ongoing basis. If you would like your project to be listed here, please get in touch with us. See also SweCRIS, a database of all funded research projects in Sweden, where it is possible to search using custom keywords.

A list of all ethically approved clinical studies on COVID-19 in Sweden up until October 2020 can be found here (only in Swedish).

Last updated: 2021.03.23

Funder
Swedish Research Council
SciLifeLab / Knut and Alice Wallenberg Foundation
NordForsk
Vinnova
Horizon 2020
Hjärt-Lungfonden
PI affiliation
Chalmers University of Technology
Karolinska Institute
Karolinska University Hospital
KTH Royal Institute of Technology
Linköping University
Luleå University of Technology
Lund University
Lund University Hospital
Sahlgrenska University Hospital
Stockholm University
Swedish University of Agricultural Sciences
Umeå University
University Hospital of Umeå
University of Gothenburg
Uppsala University
Uppsala University Hospital
Örebro University
Project title Principal investigator PI affiliation Funder Duration
Uppsala COVID-19 ICU Biobank Michael Hultström Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Building Capacity - the Sahlgrenska Covid-19 Biobank Magnus Gisslén University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
COVID-UMU: Sample collection and understanding the transition from mild to severe COVID-19 Clas Ahlm Umeå University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Assessment of SARS-CoV-2 specific antibodies in adults, and building a repository of samples from seroconverted asymptomatic adults Åsa Torinsson Naluai University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
The spread of SARS-CoV-2 monitored by the serum samples routinely obtained through maternal screening and blood donor screening Martin Sundqvist Örebro University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
The COMMUNITY Study - COVID-19 Biomarker and Immunity Study Charlotte Thålin Karolinska Institute / Danderyd Hospital SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2022
Establishing a biobank of clinical specimens for studying evolution of viral diversity and development of immune response, including inflammation, seroprevalence and protective antibodies, in SARS-Cov2 infection (Biobank) Patrik Medstrand Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
A biomarker-based approach to rapidly identify COVID-19 patients at high risk of severe disease and mortality at 3 emergency departments in Region Skåne Toralph Ruge Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Simple and cheap remote test for infection based on HCR Björn Högberg Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
COVID-19 screening test design Masood Kamali-Moghaddam Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
iLACO-Sweden Vicent Pelechano Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Extraction-free high-sensitive RT assay for SARS-CoV-2 RNA detection Björn Reinius Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
RCA-COVID-DIA Mats Nilsson Stockholm University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
COVseq – Developing COVseq for mass-scale SARS-CoV-2 sequencing Nicola Crosetto Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
A community resource for SARS-CoV-2 structure, interactome and evolution Arne Elofsson Stockholm University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Rapid cDNA and direct RNA sequencing of SARS-CoV-2 using Oxford Nanopore Lars Feuk Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Analysis of essential genes and validity as drug targets Tomas Nyman Stockholm University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Optimized expression of the SARS-Cov-2 Spike protein in mammalian cells for serology testing and functional studies Fredrik Sterky University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Production of SARS-CoV-2 surface proteins in HEK293 cells* Juni Andréll Stockholm University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Biological investigations of Covid-19 in cancer patients Gunilla Enblad Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Peptides for serological test of COVID-19 antibodies and as molecular tools Ulf Göransson Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Seroprevalence and predictors of COVID-19 disease severity in two areas of Sweden Anne Lindberg Umeå University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Large-scale production of a bio-safe antigen of COVID-19 and chimeric bat coronaviruses Kenta Okamoto Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Translational serology for a population-wide assessment of Covid19 immunity Jochen Schwenk KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Multiplex analysis of immune response against Covid-19 Sofia Hober KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Rapid development of novel antibody assays diagnosing Covid-19 Jan-Åke Liljeqvist University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Human antibodies against the SARS-CoV-2 spike protein Mats Ohlin Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Characterization of the B cell response during SARS-CoV-2 infection Karin Loré Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
PLA-based large-scale analysis of Corona virus immunity Ulf Landegren Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Neutralizing human B-cell derived monoclonal antibodies to SARS-CoV-2 Pontus Nordenfelt Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
SICoV – Serological Investigations on SARS-CoV-2 and other coronaviruses – improveddiagnostics and knowledge Åke Lundkvist Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Validation and characterisation of novel plasma biomarkers for risk prediction and stratification of COVID-19 patients Jacob Odeberg KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2022
Prediction of severe disease in Covid-19 Lars-Magnus Andersson University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Taking back the control of the SARS-CoV2 antiviral immune response as a mean to neutralize the COVID19 disease pathogenicity Marie Larsson Linköping University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Systems immunology analyses of the cytokine storm in COVID-19 Petter Brodin Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Establishing a biobank of clinical specimens for studying evolution of viral diversity and development of immune response, including inflammation, seroprevalence and protective antibodies, in SARS-Cov2 infection (Research project) Patrik Medstrand Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Dynamics and longevity of the specific adaptive immune response in COVID-19 patient Davide Angeletti University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Immediate molecular response to SARS-CoV-2 infection Jonas Klingström Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Mapping SARS-CoV-2 host-pathogen interactions for drug repurposing Ylva Ivarsson Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Viral-host interaction of SARS-CoV-2 protein corona Maria Pernemalm Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Profiling of host proteins associated to the envelope of SARS-CoV-2 Claudia Fredolini KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Genetic screens to identify novel determinants of SARS-CoV-2 infection Oscar Fernandez-Capetillo Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Cellular thermal shift assay (CETSA) to identify host factors involved in SARS-CoV-2 entry and replication Leo Hanke Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Identification of host factors targeted by coronaviruses by Thermal proteome profiling Oscar Fernandez-Capetillo Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Creating synthetic biology tools to reveal the determinants of SARS-CoV-2 interactions with host cells Erdinc Sezgin Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Human precision cut lung slices as an ex vivo model for studying SARS-CoV2 infection and identifying potential therapies Darcy Wagner Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Identifying the Achilles heel of SARS-CoV-2 by using gene scissors Claudia Kutter KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
NEVERMORE COVID – Establishing a drug discovery platform for corona virus disease Kristian Sandberg Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2022
A high-quality drug repurposing set Anna-Lena Gustavsson Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Multi-level profiling of Coronavirus-infected cells by combining Viral Entry Assays, Cell Painting, and DrugSEQ Ola Spjuth Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Spatial single cell mapping of SARS-CoV-2 interacting host proteins for quick and targeted drug repurposing Charlotte Stadler KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
FragCor – Fragment based NMR screen targeting SARS-Cov-2 proteins Göran Karlsson University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
An adaptable therapeutic technology platform to treat SARS-CoV infections in immune suppressed individuals Sara Mangsbo Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Rapid testing for treatment of Covid-19 Kristina Nyström Sahlgrenska University Hospital SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Discovery of SARS-CoV-2 Inhibitors by Virtual Screening of Ultra-large Chemical Space Jens Carlsson Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Chemographic characterization of compounds binding to seven identified molecular targets from SARS-CoV-2 Anders Backlund Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Distributed computing to generate the druggable conformational ensemble of sars-cov-2 proteins Lucie Delemotte KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
ARS-CoV-2 in sewage water as a tool for monitoring the potential circulation of the viruses in the population and rate of infections (SARS-CoV-2) Zeynep Cetecioglu Gurol KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Sewage as a proxy for SARS-CoV2 prevalence Maja Malmberg Swedish University of Agricultural Sciences SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Detection, monitoring and genetic evaluation of SARS-CoV2 in wastewater treatment plants Anna J. Székely Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Surface persistence and SARS-CoV-2 exposure in the Stockholm Subway Klas Udekwu Swedish University of Agricultural Sciences SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
A multi-level digital twin framework for Covid-19: from mechanisms of disease ethiology, to clinical decision-support and epidemiology Gunnar Cedersund Linköping University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Building a platform with AI models, datasets and web applications for fighting COVID-19 Emma Lundberg KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Artificial intelligence-based knowledge curation to direct COVID-19 research and public health efforts Sonja Aits Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
COVID-19 – a population-based project of ICU patients Emma Larsson (will be combined with project below) Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Characterization of ICU treated COVID patients in Sweden Jonathan Grip (will be combined with project above) Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Rapid testing of SARS-Cov-2 in national coordination with health care Lars Engstrand Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Development of high-throughput serology testing capability Peter Nilsson, Sophia Hober KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Sampling of COVID-19 patients for analysis of disease pathogenesis Hans-Gustaf Ljunggren Karolinska University Hospital SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
Sampling of COVID-19 patients for analysis of disease pathogenesis Hans-Gustaf Ljunggren Karolinska University Hospital SciLifeLab / Knut and Alice Wallenberg Foundation 2020 - 2021
The immunology of adverse events to SARS-CoV-2 vaccines Petter Brodin Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Register-based large-scale national population study to monitor Covid-19 vaccination effectiveness and safety (RECOVAC) Fredrik Nyberg University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
The Stockholm 65PLUS cohort- A prospective longitudinal study of immune responses induced after Covid-19 vaccination Anna-Lena Spetz Stockholm University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Impact of immune suppressants on SARS-CoV 2 vaccination responses Fredrik Piehl Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
SARS-CoV-2 infections in relation to vaccination among healthcare workers of the Stockholm Region Joakim Dillner Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Immune responses to COVID-19 vaccination in unexposed, previously infected and immunosuppressed individuals Anna Lundgren University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
CoVASC - Covid Vaccination Antibody structural correlates Johan Malmström Lund University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Covid-19 vaccination in immunocompromised individuals: An interdisciplinary framework to gain mechanistic insight into durable immunity to SARS-CoV-2 infection Soo Aleman Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Efficacy and immunogenicity of a SARS-CoV-2 vaccine in highly immunocompromised recipients of CAR T cell therapy and allogeneic stem cell transplantation Karin Loré Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
High Resolution Analysis of Vaccine-Induced Responses in SARS-CoV-2 Experienced Individuals Mattias Forsell Umeå University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Targeting blood monocytes and monocyte-derived macrophages to prevent lung injury in COVID-19 Tim Willinger Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Role of unconventional T cells in acute COVID19 disease, convalescence, and long-COVID syndrome Johan K. Sandberg Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Role of adaptive immune receptor gene polymorphisms in SARS CoV-2 infection Gunilla Karlsson Hedestam Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Metatranscriptomics in covid-19 patients in order to find new host biomarkers, and elucidate microbial responses Birgitta Henriques-Normark Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Loss of chromosome Y (LOY) in specific subtypes of leukocytes may predispose to severe course of covid-19 in males; consequences of LOY for the immune system Jan Dumanski Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Development of antivirals targeting the SARS-CoV-2 deubiquitinase PLpro Nico Dantuma Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
STARSS: A new fluorescence-based method to measure virions interaction and maturation through rotational mobility Ilaria Testa KTH Royal Institute of Technology SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Organotypic human 3D tissue models for mechanistic studies and antiviral drug development Volker Lauschke Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
The Sahlgrenska Collaborative Covid-19 Research Project Magnus Gisslen University of Gothenburg SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Mechanisms of acute and long-term organ dysfunction in critical COVID-19 Michael Hultström Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Neurological complications of COVID-19 Elham Rostami Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
MOLRES-COV Åke Lundkvist Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Immune dysregulation in patients with long-COVID Petter Brodin Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Efficient Point-of-Care and Variant Detection of SARS-CoV-2 and Other Viruses Vicent Pelechano Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
High throughput SARS-CoV-2 variant surveillance Lars Feuk Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Advancing environmental virus profiling and risk assessment for public health perspective Anna J. Székely Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
CoronaLeadDiscovery (CoLD) Helena Danielson Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
A new year, a new threat: detailed molecular investigations of novel SARS-CoV-2 Variants of Concern (VOC) transmission and pathogenesis Jonas Klingström Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Identification of druggable coronavirus-human protein-protein interactions Ylva Ivarsson Uppsala University SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
AI-driven drug and target prioritization for COVID-19 Päivi Östling Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Fast and accurate drug screening and virus surface profiling Erdinc Sezgin Karolinska Institute SciLifeLab / Knut and Alice Wallenberg Foundation 2021 - 2022
Glycan-based antivirals against SARS-CoV-2 and future pandemic viruses Niklas Arnberg Umeå University Swedish Research Council 2020-08-01 - 2020-12-31
Cellular-mediated immunity against SARS-CoV-2 Marcus Buggert Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Organization and response to covid-19 of municipal health and social care of older people – impact on mortality and health care utilization in Region Stockholm Bo Burström Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Convalescent plasma for treatment of COVID-19: A randomized controlled trial Joakim Dillner Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Digital care and Covid-19: The scope for scaling up digital care in a time of an infectious pandemic in Sweden Björn Ekman Lund University Swedish Research Council 2020-08-01 - 2020-12-31
Collateral damage of COVID-19 in older adults: short and long-term health consequences of the epidemic outbreak Laura Fratiglioni Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Targeting the most severely affected in the COVID-19 pandemic: older adults’ medications and other crucial factors in large nationwide data Kristina Johnell Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Characterization of SARS-CoV-2 specific antibody and T cell responses over time after infection: predicting the future by understanding correlates to protection Jonas Klingström Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Attenuation of SARS-CoV-2 infectivity and hyperinflammation in Covid-19 by heparin-related polysaccharides Jin-ping Li Uppsala University Swedish Research Council 2020-08-01 - 2020-12-31
Antibody specificities for protective immunity after Covid-19 vaccination Karin Loré Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Effect of face-masks during air-borne pandemics from fluid mechanical aspects Staffan Lundström Luleå University of Technology Swedish Research Council 2020-08-01 - 2020-12-31
Exploring immunologic and genetic factors in COVID-19 with relevance for immunity and long-term health: a new BAMSE follow-up Erik Melén Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Mechanistic and therapeutic studies of the innate immune response in human subjects with COVID-19 Bo Nilsson Uppsala University Swedish Research Council 2020-08-01 - 2020-12-31
Neutrophil Extracellular Traps as Potential Driver of COVID-19 Mia Phillipson Uppsala University Swedish Research Council 2020-08-01 - 2020-12-31
Covid-19 epidemic in Sweden and cardiometabolic disease: using available data from Swedish registers. Annika Rosengren University of Gothenburg Swedish Research Council 2020-08-01 - 2020-12-31
Inhibiting Corona virus-RNA translation with existing antibiotics and other small molecules Suparna Sanyal Uppsala University Swedish Research Council 2020-08-01 - 2020-12-31
Evaporation dynamics of COVID-bearing droplets under different atmospheric conditions Gaetano Sardina Chalmers University of Technology Swedish Research Council 2020-08-01 - 2020-12-31
Diary of a pandemic: Monitoring of work-related stress symptoms among healthcare workers through a mobile application. Aleksandra Sjöström-Bujacz Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Understanding respiratory and systemic immune responses during COVID-19: Implications for prediction of disease severity Anna Smed-Sörensen Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Covid-19 and androgen deprivation therapy for prostate cancer. Populationbased studies Pär Stattin Uppsala University Swedish Research Council 2020-08-01 - 2020-12-31
A genetic trap for small molecule inhibitors of the SARS-CoV-2 main protease Per Sunnerhagen University of Gothenburg Swedish Research Council 2020-08-01 - 2020-12-31
Antival compunds against CoV-2 helicase Anders Sönnerborg Karolinska Institute Swedish Research Council 2020-08-01 - 2020-12-31
Intravenous immunoglobulin to dampen covid-induced cell damage and hyperinflammation Agnes Wold University of Gothenburg Swedish Research Council 2020-08-01 - 2020-12-31
Immunological correlates of protection in COVID-19 disease and after COVID-19 vaccination Anna Smed Sörensen Karolinska Institute Swedish Research Council 2021-01-01 - 2023-12-31
Stochastic modelling of epidemic outbreaks - post Covid-19 Tom Britton Stockholm University Swedish Research Council 2020-12-01 - 2024-11-30
Wuhan Interaction with Stockholm Evidence-based Research (WISER) project on health perspectives in the older population facing the SARS-CoV-2 outbreak Sara Hägg Karolinska Institute Swedish Research Council 2021-01-01 - 2023-12-31
Mucosal immunity against SARS-CoV-2 – an unexplored field Qiang Pan-Hammarström Karolinska Institute Swedish Research Council 2021-01-01 - 2023-12-31
Preventing paediatric pneumonia deaths in Nigeria Carina King Karolinska Institute Swedish Research Council 2020-12-01 - 2022-12-31
Interdisciplinary framework on the role of adaptive cellular immunity in SARS-CoV-2 protection Marcus Buggert Karolinska Institute Swedish Research Council 2021-01-01 - 2023-12-31
Innate-like unconventional T cells as new regulators of the immune response against viral infection Andrea Ponzetta Karolinska Institute Swedish Research Council 2020-12-01 - 2023-12-31
ARCTIC: contAct tRaCing prevenTion of Covid-19 Carlo Fischione KTH Royal Institute of Technology Swedish Research Council 2020-12-01 - 2021-12-31
Creation of a COVID-19 Immune Atlas to rapidly repurpose available drugs targeting signaling and metabolism of immune cells Martin Cornillet Jeannin Karolinska Institute Swedish Research Council 2020-12-01 - 2023-12-31
Decoding heterogeneity and durable immunity of lung resident memory T cells in health and acute respiratory infection Takuya Sekine Karolinska Institute Swedish Research Council 2020-12-01 - 2023-12-31
Living with microbial roommates: Health literacy capability in antimicrobial resistance education Martin Mickelsson Uppsala University Swedish Research Council 2021-01-01 - 2023-12-31
Design and development of mucosal vaccine vectors in commensal bacteria expressing SARS-CoV-2 antigens as a potential prophylactic method Lars Engstrand Karolinska Institute Swedish Research Council 2020-12-01 - 2021-12-31
Large-scale national initiative assessing symptoms, exposures and risk factors for Covid-19: COVID Symptom Study Sweden. Using a free smartphone app to facilitate real-time data collection of symptoms, exposures, and risk factors related to Covid-19. Paul Franks, Maria Gomez Lund University Swedish Research Council, Hjärt-Lungfonden, Swedish Foundation for Strategic Research 2020-04-29 - 2024-10-01
Addressing the smoking paradox in the etiology of COVID-19 through population-based studies Maria Rosaria Galanti Karolinska Institute NordForsk 2020 - 2022
Data streams and mathematical modelling pipelines to support preparedness and decision making for COVID-19 and future pandemics Tom Britton Stockholm University NordForsk 2020 - 2022
Antibodies against SARS-CoV-2 verification of commercially available assays and a nuanced sustainable approach Anna Fogdell-Hahn Karolinska Institute Vinnova 2020-07-01 - 2021-06-30
Identification of epitopes on SARS-CoV-2 viral particles for rapid development of neutralizing antibodies Owe Orwar Oblique Therapeutics AB Vinnova 2020-09-01 - 2021-12-31
Validation of a fast and effective Corona diagnostic test for the healthcare system Yalda Bogestål RISE Research Institutes of Sweden Vinnova 2020-05-11 - 2020-10-30
Targeting the SARS-CoV-2 spike protein to achieve hyperimmunicity and reduce infectivity Rickard Nordén Angered Hospital Vinnova 2020-10-01 - 2021-03-31
SARS-Cov-2 sensor for rapid sensitive virus detection Börje Sellergren SureCapture Technologies AB Vinnova 2020-07-01 - 2021-06-30
Evaluating therapeutic potential of integrin 10-selected MSCs in treatment of COVID-19 (ARDS) Caroline Ehrencrona Xintela AB Vinnova 2020-05-08 - 2020-11-30
Fighting-off coronavirus (SARS-CoV-2) with broad-spectrum antivirals: establishing animal viral challenge model Anna-Lena Spetz Stockholm University Horizon 2020 2020-04-01 - 2022-03-31
Antibody therapy against coronavirus (COVID-19) Qiang Pan Hammarström, Harold Marcotte, Lennart Hammarström Karolinska Institute Horizon 2020 2020-04-01 - 2022-03-31
Rapid therapy development through Open Coronavirus Vaccine Platform Matti Sällberg, Gustaf Ahlén Karolinska Institute Horizon 2020 2020-04-01 - 2022-03-31
Nanobodies and antibodies against 2019-nCoV Benjamin Murrell, Gerald McInerney, Gunilla Karlsson Hedestam Karolinska Institute Horizon 2020 2020-04-01 - 2022-03-31
Hur coronavirus kan inverka vid hjärtstopp Araz Rawshan Sahlgrenska University Hospital Hjärt-Lungfonden -
Rätt behandling vid Covdi-19 hjärtmuskelskada Björn Redfors Sahlgrenska University Hospital Hjärt-Lungfonden -
Hur hjärtat påverkas vid Covid-19 inflammation Henrik Engblom Karolinska Institute Hjärt-Lungfonden -
Faktorer som påverkar sjukdomsförloppet vid covid-19 Caroline Stridsman Umeå University; Sunderby hospital Hjärt-Lungfonden -
Identifiering av vad som orsakar lungsvikt hos svår covid-19 Johan Erjefält Lund University Hospital Hjärt-Lungfonden -
Minska negativa effekterna av respiratorvård Lars Larsson Karolinska Institute Hjärt-Lungfonden -
Orsakerna till andningssvikt vid dödsfall i covid-19 Anders Blomberg University Hospital of Umeå Hjärt-Lungfonden -
Bakteriella infektioner vid covid-19 Birgitta Henriques Normark Karolinska Institute Hjärt-Lungfonden -
Mekanismerna bakom svår covid-19 Bo Nilsson Uppsala University Hospital Hjärt-Lungfonden -
Mänsklig genetik relaterad till covid-19 Romeo Stefano University of Gothenburg; Sahlgrenska University Hospital Hjärt-Lungfonden -
Tidiga tecken på bestående lungsjukdom Gunilla Westergren-Thorson Lund University Hospital Hjärt-Lungfonden -
Kliniska immunologiska parametrar för att förrutsäga skydd mot reinfektion Mats Bemark Sahlgrenska University Hospital Hjärt-Lungfonden -
Utvärdeing av behandling med ECMO vid covid-19 Magnus Dalén Karolinska University Hospital Hjärt-Lungfonden -
Utvärdering av astmamedicin för covid-19 Daniel Andersson Karolinska Institute Hjärt-Lungfonden -
Uppföljning av svår luftvägsinfektion av covid-19 Judith Bruchfeld Karolinska University Hospital Hjärt-Lungfonden -
Förstå andnings och immunsystem under covid-19 Anna Smed-Sörensen Karolinska University Hospital Hjärt-Lungfonden -
Sjukdomens svårighetsgrad jämförs mellan olika regioner Anne Lindberg Umeå University Hjärt-Lungfonden -
Sjukdomsförebyggande av covid-19 med etablerade mediciner Johan Sundström Uppsala University Hospital Hjärt-Lungfonden -
Studie av 'mördar' celler inför vaccinutveckling Kristian Riebeck Skåne University Hospital Malmö Hjärt-Lungfonden -
Brist på visst protein ökar risk för svår covid-19 Maria Thunander Lund University Hjärt-Lungfonden -
Vaccin mot SARS-CoV-2 Jan Lötvall Sahlgrenska University Hospital Hjärt-Lungfonden -
Identifiering av genetiska riskfaktorer vid covid-19 Magnust Nordenskjöld Karolinska Institute Hjärt-Lungfonden -
Hur påverkas epigenetiska mönster i arvsmassan av covid-19 Maria Lerm Linköping University Hjärt-Lungfonden -